Idiopathic CD4 ⍣ lymphocytopenia (ICL) is defined by a stable loss of CD4 ⍣ T cells in the absence of any known cause of immune deficiency. This syndrome is still of undetermined origin. It affects adult patients, some of them displaying opportunistic infections similar to HIV-infected subjects. The hypothesis that the cellular immune defect may be due to biochemical failures of the CD3-TCR pathway is investigated here in a patient associating a severe selective CD4 ⍣ lymphocytopenia with an increased CD8 ⍣ T cell count discovered in the course of a cryptococcal meningitidis. A 40% reduction of T cell proliferation to CD3-TCR stimulation is observed only in the CD4 ⍣ subpopulation. The early CD3-induced protein tyrosine phosphorylations are conserved in both CD4 ⍣ and CD8 ⍣ subsets, and the levels of the T cell protein tyrosine kinases p56 Lck , p59 Fyn and ZAP-70 are normal. However, we find a 50% reduction of p56 Lck kinase activity in the patient's T cells compared to a healthy control donor. p59 Fyn activity does not appear to be altered. Nevertheless, we do not find any genetic abnormality of p56 Lck . These results thus suggest that a defect of an unknown protein regulating p56 Lck activity takes place in this patient's T cells. Taken together, these findings reveal p56 Lck alteration in ICL and confirm the critical role of this kinase in the maintenance of the peripheral CD4 ⍣ T cell subpopulation.
Introduction
Idiopathic CD4 ϩ lymphocytopenia (ICL) is a rare immuno- (2, 7, 8, 10) . In addition to the CD4 ϩ lymphocytopenia, several patients also display a CD8 ϩ lymphocytopenia while low B deficiency syndrome affecting 0.5-2% of adults (1-3). It is defined by a low CD4 ϩ T cell count Ͻ300/µl or a percentage or NK cell counts have also been reported in others (2, 8, 10) . The heterogeneity of ICL does not favor the hypothesis of a of CD4 ϩ T cells Ͻ20% on at least two occasions, without HIV infection or any known immune defect (4) . The origin of this unique cause (3, 11) and some authors have suggested ICL to be classified among common variable immunodeficiency syndrome is currently not known. Although Laurence et al. (5) and Gupta et al. (6) suggested in 1992 that ICL could (7) . Similarly, we previously suggested that a case of ICL associated with recurrent opportunistic infections could be be due to a new retrovirus distinct from HIV-1 and HIV-2, epidemiologic studies showed no evidence for a transmissible attributed to a primary immunodeficiency disorder (12) . Recently, Laurence et al. demonstrated that increased agent (2, 7) . ICL differs from HIV infection by stable levels of CD4 ϩ T cell counts in contrast to the progressive loss of this spontaneous and activation-induced apoptosis was associated with symptomatic ICL, and might represent one physisubpopulation observed in the course of HIV disease (7) (8) (9) . Moreover, a great heterogeneity in the symptomatology and opathologic mechanism of the disease (13) . Alternatively, other studies reported proliferative T cell defects to mitogens the T cell phenotypic abnormalities have been reported among patients with ICL. Indeed, ICL can be diagnosed with or antigens in patients with ICL and opportunistic infections (6) (7) (8) 12) . It was thus of interest to evaluate whether the the onset of opportunistic infections or among autoimmune disorders, whereas it remains asymptomatic in other patients immune deficiency was determined solely by the severity of the lymphocytopenia or whether the residual lymphocytes also were expanded in complete medium containing 20 IU/ml of recombinant IL-2 (Boehringer Mannheim, Meylan, France) for displayed molecular abnormalities responsible for defective T cell activation and proliferation. The T cell activation process at least 15 days before use. Purified CD8 ϩ T cells were obtained by negative selection. consists in a cascade of biochemical events triggered by PHA-blasts were incubated with an anti-CD4 mAb from stimulation of the CD3-TCR by the MHC-peptide complex or Coulter-Immunotech (Marseille, France) for 1 h at 4°C. After by a mAb specific to CD3ε. The earliest events involve the washing, cells were incubated for 1 h at 4°C with sheep T cell protein tyrosine kinases (PTK) p56 Lck , p59 Fyn and anti-mouse-coated magnetic beads (Dynal, Oslo, Norway). ZAP-70, which phosphorylate numerous intracellular subNegative-selected CD8 ϩ T cells were ജ90% pure. strates on tyrosine residues (tyrosine phosphorylation), further leading to cytokine gene expression and cell proliferation Antibodies and reagents (18, 19) . Supporting this hypothesis, children with severe
The following mAb were used for labeling surface antigens: combined immunodeficiency (SCID) determined by defective anti-CD4 (clone Leu3a) and anti-CD8 (clone Leu2a) mAb expression of the PTK ZAP-70 display a profound depletion coupled with PerCP from Becton Dickinson; anti-CD8 mAb of peripheral CD8 ϩ T cells. The absolute counts of CD4 ϩ coupled with phycoerythrin (PE) from Immunotech; and anti-T cells are normal in these patients, although these cells have CD25, anti-HLA DR, anti-CD45RA and anti-CD45RO mAb a defect of the CD3-TCR signal transduction pathway (14- coupled with FITC from Immunotech. 16). Moreover, a defective expression of the PTK p56 Lck was
The anti-CD3ε mAb UCHT1 (IOT3) was purchased from recently shown in a SCID child who had also a selective loss Immunotech or was used as an ascitic fluid for T cell stimulaof CD4 ϩ T cells (17) .
tion, alone or in combination with a polyclonal rabbit antiIn this paper, we analyzed the CD3-TCR pathway of the mouse IgG serum (RAM) obtained from Sigma-Aldrich (St CD4 ϩ and CD8 ϩ T cell subsets from a patient with severe Quentin Fallavier, France). and stable ICL revealed by an opportunistic infection, in order
The FITC-conjugated anti-BrdU mAb (clone B44) was proto investigate whether impaired activation events in these vided by Becton Dickinson. The biotinylated and the unlabeled cells might explain the T cell depletion and the immune anti-phosphotyrosine mAb (clone 4G10) were obtained from deficiency. We studied T cell proliferation and early protein UBI (Lake Placid, NY). Anti-p56 Lck , anti-p59 Fyn and antityrosine phosphorylations at the cellular level by coupling ZAP-70 mAb used for Western blotting experiments were functional tests with flow cytometric analysis, together with purchased from Transduction Laboratories (Affiniti Research biochemical analysis of T cell PTK.
Products, Nottingham, UK). Polyclonal rabbit serum antip56 Lck specific for the N-terminus (NT) of the PTK and polyclonal rabbit serum anti-NT-p59 Fyn were obtained from Methods UBI and used for immunoprecipitations.
Patient and controls
BSA, paraformaldehyde (PFA), saponin, DNase I and BrdU were purchased from Sigma. FACS lysing solution was proThe patient described here was a 66-year-old woman, who vided by Becton Dickinson. PBS was from Gibco/BRL (Life had a selective CD4 ϩ lymphocytopenia stable for 10 years, Technologies, Cergy-Pontoise, France). [ 3 H]Thymidine (2 Ci/ discovered in the course of a cryptococcal meningitidis (20) . mmol) was obtained from ICN (Orsay, France) and [γ-32 P]ATP Since then, she remained asymptomatic and did not receive (3000 Ci/mmol) was from Amersham-Pharmacia Biotech any treatment at time of the study. She was found to be (Orsay, France). negative for HIV infection by serologic and PCR assays. Informed consent was obtained before the study.
Lymphocyte counts and phenotypes Cells of adult healthy volunteer donors from the blood donor Absolute counts of CD4 ϩ and CD8 ϩ T cells were determined center of the Pitié -Salpê triè re Hospital were used as controls from whole blood samples on the Epics XL flow cytometer for each assay.
using the Flow-Count Fluorospheres system (Coulter, Miami, FL).
Cell preparation and culture
Lymphocyte phenotypes were studied by three-color flow Whole blood samples were collected on heparinized Vacucytometry on whole blood samples using PerCP-anti-CD4 tainer tubes (Becton Dickinson, San Jose, CA) by venous mAb, PE-anti-CD8 mAb and either FITC-conjugated mAb puncture of patients or control donors. They were used directly specific for HLA DR, CD25, CD45RA or CD45RO according to for cytometric tests realized on whole blood. standard procedures. Cells were analyzed on a FACSCalibur Peripheral blood mononuclear cells (PBMC) were isolated cytofluorometer (Becton Dickinson) fitted with a 15 mW airfrom whole blood by Ficoll-Hypaque (Eurobio, Les Ulis, cooled argon-ion laser emitting at 488 nm. Green, orange France) density-gradient centrifugation. Cells were then culand red fluorescences were calibrated by using CaliBRITE tured for the indicated period of time and with the indicated beads (Becton Dickinson). Forward scatter, side scatter, FITC, stimulating agent in complete medium: RPMI 1640 medium PE and PerCP fluorescent signals were detected by using (Flow, Irvine, UK) supplemented with 10% FCS, 50 U/ml standard procedures, and data were analyzed with CellQuest penicillin, 50 µg/ml streptomycin, 2 mM L-glutamine and 1 software (Becton Dickinson). mM sodium pyruvate.
Cell proliferation assays using [ 3 H]thymidine incorporation Phytohemagglutinin (PHA)-induced T cell blasts (PHAblasts) were obtained by culturing PBMC with PHA (2 µg/ml) PBMC were cultured at 1ϫ10 5 cells/well in triplicate in a 96-well microtiter plate with complete medium alone or with for 3 days in complete medium. After washing, T cell blasts a Phenotypes were studied by three-color immunofluorescence. Absolute counts of CD4 ϩ and CD8 ϩ T cells were determined by using the Flow-Count fluorospheres system from Coulter.
b Proliferation was analyzed by stimulating PBMC (100,000 cells/well in triplicate) with medium or coated anti-CD3 mAb for 72 h. or the CD8 ϩ subpopulation. Cells were then harvested and radioactivity was measured Analysis of CD3-induced protein tyrosine phosphorylation in on a β-counter (Beckman, Palo Alto, CA).
T cell subsets by flow cytometry Cell proliferation assays using BrdU labeling
Quantification of cellular tyrosine kinase activities was performed as recently described (22) . Briefly, whole blood BrdU incorporation assays were performed according to the method of Carayon et al. (21) modified as followed. PBMC samples (400 µl/condition for the lymphopenic patient and 200 µl/condition for controls) were stimulated with anti-CD3 from the patient or healthy blood donors were incubated at 10 6 cells in 1 ml of complete medium in a 24-well flat-bottom mAb UCHT1 (5 µg/ml) and RAM (16 µg/ml) or with medium alone at 37°C for 3 min for CD4 ϩ T cells or for 1 min for CD8 ϩ microtiter plate either uncoated or coated with the anti-CD3 mAb UCHT1 (5 µg/ml). After 64 h of culture at 37°C, BrdU T cells. Activation was stopped by washing with cold PBS/BSA/ NaN 3 and rapid centrifugation. Blood pellets were labeled with (30 µg/ml) was added in each well for 1 h. Cells were then harvested, washed in PBS containing 0.5% BSA and 0.02% PerCP-anti-CD4 or PerCP-anti-CD8 mAb and red blood cells were then lysed with FACS lysing solution. Cells were subsodium azide (PBS/BSA/NaN 3 ), and surface labeled with 20 µl of PerCP-anti-CD4 or PerCP-anti-CD8 mAb. After washing, sequently permeabilized with PBS/PFA 4% and PBS/BSA/ saponin. Intracellular labeling was performed with 10 µg/ml cells were fixed with 200 µl of PBS, pH 7.5, containing 4% PFA (PBS/PFA 4%) for 20 min at room temperature with gently of the biotinylated anti-phosphotyrosine mAb 4G10 for 30 min at 4°C and streptavidin-FITC (20 µg/ml). Samples were finally agitation. Cells were further permeabilized by washing with PBS/BSA/NaN 3 containing 0.1% saponin (PBS/BSA/saponin).
analyzed for FL1 and FL3 fluorescence intensities on the FACSCalibur cytometer. Viable cells, and CD4 ϩ and CD8 ϩ DNA was denatured with 50 U Kunitz units of DNase I from bovine pancreas (Sigma; DN-25) in 1 ml of PBS containing 5 populations were gated as above. In total, 2500 events were analyzed for each CD4 ϩ or CD8 ϩ T cell subset. mM MgCl 2 . After a wash with PBS/BSA/saponin, cells were labeled with 20 µl of FITC-anti-BrdU mAb in 50 µl of PBS/
Western blotting experiments BSA/saponin for 30 min at 4°C. Cells were analyzed on the FACSCalibur cytometer as above. After gating viable For the study of the protein tyrosine phosphorylation process, purified CD8 ϩ PHA-blasts (5ϫ10 6 per condition of stimulation) lymphocytes on forward and side scatters, CD4 ϩ or CD8 ϩ T cells were gated on the FL3 fluorescence intensity. The were washed in RPMI containing 10 mM HEPES, pH 7.2, and equilibrated for 10 min at 37°C. Cells were then incubated pcDNA3 vector. Sequences were performed on a ABI Prism 377 automated DNA sequencer (Perkin-Elmer, Foster City, with the UCHT1 mAb (1:500 dilution of the ascitic fluid) or CA). with medium alone for 1 min at 37°C. Activation was stopped by brief centrifugation and transfer on ice and cells were lysed in lysis buffer (Tris-HCl 20 mM, pH 7.5, EDTA 1 Results mM, NaCl 140 mM, 1% NP-40, aprotinin 50 U/ml, sodium orthovanadate 1 mM and PMSF 1 mM) at 4°C for 15 min. For
Phenotypic characteristics of T lymphocytes the study of PTK expression, cells were lysed immediately A severe selective CD4 ϩ lymphocytopenia (100-156/µl) was after washing. Nuclei and cellular debris were removed by associated with increased CD8 ϩ T cell counts (~1000/µl), centrifugation. After dilution in Laemmli sample buffer (Trisboth remaining stable during the 10-year follow-up (Table 1 ) HCl 500 mM, pH 6.8, 10% SDS, 10% glycerol, 5% 2-mercapto- (20) . The expression levels of CD4 and CD8 antigens were ethanol and 10% bromophenol blue) and boiling for 5 min, comparable in the patient's and control cells (data not shown). the same amount of proteins per sample determined by using
The B cell (CD19 ϩ ) and NK cell (CD3 -CD16 ϩ CD56 ϩ ) percentthe Bradford assay was loaded on an 8% SDS-polyacrylamide ages were also stable and within the normal ranges. minigel (Novex, San Diego, CA). Proteins were electrophorExamination of ex vivo T cell activation status over a 6-year etically transferred to nitrocellulose sheet (Schleicher & follow-up showed that high percentages of CD4 ϩ T cells Schuell, Dassel, Germany) for 1 h at 65 V. Blots were then displayed the activation markers CD25 (29-47%) and/or HLAhybridized for 2 h with 0.2 µg/ml anti-phosphotyrosine mAb DR (13-35%) ( Table 1 ). In contrast, CD8 ϩ T cells were weakly 4G10, 1 µg/ml anti-p56 Lck mAb, 1 µg/ml anti-p59 Fyn mAb or activated, 2-6% of them displaying CD25 and the HLA-DR 1 µg/ml anti-ZAP-70 mAb, before addition of goat anti-mouse marker being expressed at normal levels. Moreover, most of antiserum labeled with peroxidase (BioRad, Richmond, CA).
the CD4 ϩ T cells were differentiated into memory cells since Reaction was revealed with an enhanced chemiluminescence 78-86% of them displayed the CD45RO isoform (23), while system (Amersham-Pharmacia Biotech) according to the sup-82-100% of CD8 ϩ T cells were CD45RA ϩ . Co-expression of plier's instructions. the CD45RO and CD45RA isoforms was however detectable on 14-55% of CD4 ϩ and 30-31% of CD8 ϩ T cells, suggesting In vitro kinase assays a recent activation of those circulating T cells (24). The cell surface expression of these activation and memory markers CD8 ϩ PHA-blasts were lysed as above and samples were on both T cell subsets also remained stable over time (Table 1) . normalized for the amount of proteins. Lysates were incubated for 2 h with 2.5 µl of rabbit anti-NT-p56 Lck or 10 µl of rabbit T cell proliferation to CD3-TCR stimulation was altered only anti-NT-p59 Fyn and immune complexes were then recovered in the CD4 ϩ T cell subset with 20 µl of Protein A-Sepharose beads for 1 h at 4°C.
To test the hypothesis of additional T cell dysfunctions, we Immunoprecipitates were washed 3 times with lysis buffer first studied the ability of T cells to proliferate in response and once with kinase buffer (50 mM PIPES, pH 6.7, 10 to CD3-TCR stimulation first by using the [ 3 H]thymidine mM MgCl 2 , 10 mM MnCl 2 , 1 mM PMSF, 50 µM sodium incorporation assay. As shown in Table 1 , the patient's PBMC orthovanadate and 2% aprotinin). Kinase assay was started proliferative responses to CD3-TCR cross-linking were similar by addition of 30 µl of kinase buffer containing 5 µM unlabeled to those of normal controls and remained stable during the ATP, 5 µCi of [γ-32 P]ATP and 2.5 µg enolase as a specific 6-year follow-up. exogenous substrate. Samples were incubated 5 min at 30°C Since patient's T cells were composed mainly by the CD8 ϩ and kinase reaction was stopped by addition of 30 µl of subpopulation (see Table 1 ), this assay did not discriminate Laemmli sample buffer. After boiling at 95°C for 5 min, between the proliferation of CD4 ϩ and CD8 ϩ T cells. We thus radiolabeled proteins were resolved by 8% SDS-PAGE and studied the proliferation of each T cell subset by using the transferred to nitrocellulose. Membranes were exposed for BrdU incorporation assay coupled to flow cytometric analysis autoradiography during the indicated period of time. Radioas described in Methods. As shown in Fig. 1 , after 64 h of activity of the bands was quantified using a β-Imager 1200 CD3 stimulation, cells from healthy donors incorporated BrdU (Biospace, Paris, France). Gel Bands were also scanned in a narrow range of values similar to those previously using a laser densitometer (BioRad).
described by Carayon et al. (21) : CD4 ϩ ϭ 46 Ϯ 5% and CD8 ϩ ϭ 54 Ϯ 6% (n ϭ 16). Interestingly, a significant RT-PCR, cloning and sequencing p56 Lck 40% decrease in the patient's CD4 ϩ T cell proliferation was RNA extraction was performed by using the RNA isolation kit observed, only 28% of them incorporating BrdU (Fig. 1) . In (Stratagene, La Jolla, CA). RNA (10 µg) was reverse trancontrast, CD8 ϩ T cells proliferated normally compared to scribed using the MMLV reverse transcriptase (RT-PCR kit controls, thus explaining the normal c.p.m. values obtained from Stratagene). p56 Lck cDNA (2.5 µl) was amplified using in the total PBMC proliferation assay using [ 3 H]thymidine (see the primers 5Ј-GGAATTCCGGGACCATGGGCTGTGGCTGC- Table 1 ). These results were stable in three experiments 3Ј and 5Ј-GCTCTAGAGCTCTCAAGGCCTCCTCTCAAG-3Ј performed over the last 3 years (mean Ϯ SD was 27.6 Ϯ under the following conditions: 94°C for 90 s, 60°C for 90 s, 1.5% for CD4 ϩ T cells and 44.6 Ϯ 2.5% for CD8 ϩ T cells), 72°C for 90 s, 30 cycles. PCR products (1500 bp) were suggesting that a specific failure to proliferate of the CD4 ϩ digested using EcoRI and XbaI restriction endonucleases T cell subset might participate in the process of CD4 ϩ T cell depletion. (Boehringer Mannheim), gel purified, and cloned into the 
Non-altered CD3-induced protein tyrosine phosphorylation pattern in purified CD8 ϩ T cell blasts CD3-induced protein tyrosine phosphorylations were con-
We then determined whether qualitative alterations of the served in CD4 ϩ and CD8 ϩ T cell subsets CD3-TCR-induced tyrosine phosphorylation pattern could be detected in the patient's T cells by using classical Western To determine whether alterations in early biochemical events of the CD3-TCR pathway might explain the defective CD4 ϩ blotting experiments. Because of the severe CD4 ϩ lymphocytopenia, only CD8 ϩ T cells could be examined, after negative T cell proliferative response, we studied the CD3-induced tyrosine phosphorylation process of cellular proteins. To anapurification from a PHA-derived cell line. The CD8 ϩ T cell blasts from the patient and a healthy control were stimulated lyze this phenomenon in each CD4 ϩ and CD8 ϩ T cell subset, we used the previously described phosphotyrosine assay with the anti-CD3 mAb UCHT1 or left unstimulated, and lysed. The same amounts of proteins for each sample (30 µg) were coupled to flow cytometric analysis (22) . This technique allows us to quantify the tyrosine phosphorylation of whole cellular migrated on a mini-SDS-PAGE and analyzed by Western blotting using the anti-phosphotyrosine mAb 4G10. As shown proteins at the cell subset level and to detect PTK activity deficiency (22) . After intracellular labeling with the anti-phosin Fig. 3 , CD3-TCR stimulation induced significant protein tyrosine phosphorylation in the patient's CD8 ϩ T cell blasts, photyrosine mAb 4G10, the amounts of spontaneous and CD3-induced protein tyrosine phosphorylations were quantiwith an intensity similar to that observed in control CD8 ϩ T cell blasts. Moreover, the tyrosine phosphorylation pattern fied by the median of the phosphotyrosine fluorescence intensity (Ptyr MFI). For each subset, results were expressed appeared identical in the patient's and control cells. Thus, this early biochemical event of the CD3-TCR pathway seemed as the ratio (R) between CD3-induced Ptyr MFI and spontaneous Ptyr MFI. One of two independent experiments is shown qualitatively conserved in CD8 ϩ T cell blasts from this patient. obtained by scanning the bands with a laser densitometer.
In addition, analysis of p56 Lck activity in five healthy subjects ( Fig. 5a and b) , showing that the kinase activity deficiency mAb 4G10 and goat anti-mouse coupled to peroxidase.
specifically affected p56 Lck . All these results were confirmed in three separate experiments and were also found in purified CD8 ϩ T cells isolated from fresh PBMC (data not shown), Normal expression but defective p56 Lck activity in CD8 ϩ suggesting that this deficiency in p56 Lck activity was a stable T cell blasts phenomenon and was not secondary to PHA activation. The kinase domain of p56 Lck has been shown to be p56 Lck is thought to be the earliest PTK to be activated after CD3-TCR stimulation (18, 19) and to play a critical role in responsible for the phosphorylation of exogenous substrates and also for the autophosphorylation of the PTK (27,28). Since CD3-TCR signaling pathway (25) as well as in T cell development (26). Moreover, defective p56 Lck expression has been a kinase-defective p56 Lck could be obtained either by deletion of the kinase domain or by mutation of the Lys273 (29,30), recently described in a child with SCID presenting a selective CD4 ϩ lymphocytopenia (17) . We thus examined the expreswe finally attempted to determine whether a sequence abnormality could be evidenced in the patient's p56 Lck cDNA. The sion of this kinase by Western blotting experiments in the patient's and control's CD8 ϩ T cell blasts. As shown in Fig.  p56 Lck RNA was extracted from the patient's PBMC and from the same control as above, and was amplified by RT-PCR. 4(a), the patient's cells displayed the same amount of p56 Lck as control cells. Similarly, the expression of each of the other
The 1500 bp band corresponding to the size of p56 Lck cDNA was gel-purified and cloned into the pcDNA3 vector. Ten T cell PTK p59 Fyn (Fig. 4b) and ZAP-70 (Fig. 4c) appeared to be identical in the patient's and control CD8 ϩ T cell blasts.
clones for each patient and control were sequenced. For both subjects, we found two types of p56 Lck cDNA, one We then analyzed the spontaneous p56 Lck activity by immunoprecipitating the kinase from unstimulated CD8 ϩ T cell corresponding to the full-length p56 Lck sequence (31) and the other corresponding to the previously described p56 Lck blast lysates. Immunoprecipitates were then subjected to in vitro kinase assay, migration on SDS-PAGE and transfer to cDNA deleted of exon 7 (17, 25) . However, no sequence disparity was found in each case between the patient's and nitrocellulose sheet. As shown in Fig. 5(a) , both p56 Lck autophosphorylation and activity toward the exogenous subcontrol p56 Lck sequences. strate enolase were reduced by 50% in patient's compared to control's CD8 ϩ T cell blasts, although the same quantity of Discussion the enzyme was precipitated in each case (Fig. 5b) . The intensity of the p56 Lck band was quantified using a β-Imager ICL defined by the criteria of the Centers for Disease Control and Prevention (4) appears to be a heterogeneous entity, at 76,640 counts for the control and 37,853 counts for the patient. Similarly, 105,731 and 50,349 counts were found for when considering either the clinical symptoms or the level of CD4 ϩ T cell depletion (2) . Hence, the mechanism(s) and the the band corresponding to the exogenous substrate for the control and the patient respectively. The same result was etiology(ies) of this syndrome are currently unknown and are likely of multiple origins (3). Here we studied a patient with a (33, 34) . Finally, our patient's finding is in accordance with the observation of the SCID child (17) who displayed a normal stable and severe loss of CD4 ϩ T cells associated with a history of clinical symptoms of cellular immune deficiency.
protein tyrosine phosphorylation process in CD8 ϩ T cells despite the absence of p56 Lck expression. These findings Since alterations of the CD3-TCR signal transduction pathway have been described in several cases of children with SCID support the hypothesis of an indirect role for the kinase domain of p56 Lck in the early tyrosine phosphorylation of associated with selective lymphocytopenia (14-16), we postulated that the immune deficiency of this patient could be whole cellular proteins. Alternatively, one could argue that a 50% reduction in p56 Lck kinase activity was not sufficient to related to molecular defects in the T cell activation process.
We found an abnormality of the PTK p56 Lck in CD8 ϩ T cells alter the protein tyrosine phosphorylation pattern. Another hypothesis would be that p59 Fyn might complement p56 Lck from our patient that might play a role in this case of ICL. Similarly, one SCID child presented a selective CD4 ϩ as previously proposed (35) , although no increased amount and activity of this PTK was evidenced in our patient's T cells. lymphocytopenia associated with an absence of p56 Lck expression in the remaining CD8 ϩ T cells (17) . However, in Defective T cell proliferation to mitogens have been described for several patients with ICL (7). The BrdU assay our case, a full-length p56 Lck was expressed in T lymphocytes which rather displayed a 50% decrease in autophosphorylallowed us to clearly demonstrate that the impaired proliferative response was observed only in the depleted CD4 ϩ T cell ation and in in vitro kinase activity. This observation contrasted with the conserved protein tyrosine phosphorylation process subpopulation. Since only live lymphocytes were gated in this assay, this proliferation defect was not due to increased induced by CD3 triggering in the patient's CD4 ϩ and CD8 ϩ T cells (see Fig. 2 ). p56 Lck is linked to CD4 and CD8 cellactivation-induced cell death (13) but rather to a true defect in the renewal capacity of peripheral CD4 ϩ T lymphocytes surface receptors (32) , and has been demonstrated to be critical for early CD3-TCR signaling pathway. Indeed, no which might participate in the selective CD4 ϩ lymphocytopenia. The degree of decreased proliferative responses of the protein tyrosine phosphorylation can be induced by CD3 stimulation in the Jurkat variant JCam1 defective for Lck patient's CD4 ϩ T cells correlated here with the level of deficiency in p56 Lck activity found in CD8 ϩ T cells (40-expression (25) . Moreover, tyrosine phosphorylation of the major in vitro autophosphorylation site of p56 Lck (tyrosine 394) 50% inhibition), rather than with the weak protein tyrosine phosphorylation defect (only 10% decrease) found in the correlates with an enhanced kinase activity (27). However, protein tyrosine phosphorylations are similarly detected after CD4 ϩ T cell subset. This finding suggested that the defective Lck kinase activity might also be present in CD4 ϩ T cells and CD3ε triggering in cells expressing a CD4-p56 Lck chimera deleted of the kinase domain or containing the entire kinase be responsible for the proliferation defect of this subset, perhaps by inhibition of downstream activation events. The domain (30). In the same way, the p56 Lck SH2 domain, rather than the kinase domain, has been shown to be critical for reason why the CD8 ϩ subpopulation was not depleted but was rather increased and was still able to proliferate normally CD3-induced intracellular protein tyrosine phosphorylation hyperactivation status or to an unknown infectious agent similar to HIV despite the lack of any evidence for epidemic transmission of ICL (2, 7) . However, in these cases, a CD4 ϩ T cell proliferation deficiency is associated with an impaired CD3-induced tyrosine phosphorylation process, and altered levels of p56 Lck and p59 Fyn (39-42). On the other hand, the patient described here might rather display a primary T cell deficiency caused by structural abnormalities of transducing molecules, similar to those found in children with inherited immunodeficiency (14) (15) (16) . Indeed, the deficiency in p56 Lck activity was observed in both freshly isolated PBMC and in cultured PHA-blasts, suggesting that this defect was not due to extracellular factors, but rather to an intrinsic T cell abnormality. The best candidate was p56 Lck itself. However, in Ͼ10 p56 Lck cDNA clone sequences examined, none were found to be different from control sequences (31) . This suggested that a defect of a yet undetermined protein kinase or alternatively an enhanced level of a cellular protein phosphatase regulating p56 Lck kinase activity might take place in T cells from the patient. Since p56 Lck tyrosine phosphorylation was similar in the patient's and control CD8 ϩ T cell blasts (data not shown), this altered protein might be a serine kinase or phosphatase. This unknown defect might thus represent a link between p56 Lck and downstream activation events, and might also account for the loss of CD4 ϩ T cell proliferation capacity and CD4 ϩ T cell depletion. Contrasting with the recent study describing a SCID child with Lck deficiency and CD4 ϩ lymphopenia who displayed clinical signs of immune 
